Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Microcephaly, Joint stiffness present at birth (arthrogryposis multiplex congenita), and Decreased fetal movement; and common findings: Talipes equinovarus, Rocker bottom foot, Enlarged brain ventricles (ventriculomegaly), and Low-set ears and others. 17 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Head and neck | 2 | Cleft palate, Microcephaly |
ERCC5 encodes ERCC excision repair 5, endonuclease (1,186 aa). Single-stranded structure-specific DNA endonuclease involved in DNA excision repair. Makes the 3'incision in DNA nucleotide excision repair (NER). Highest expression in Cells EBV-transformed lymphocytes (4.7 TPM) and Cells Cultured fibroblasts (3.5 TPM).
Cerebrooculofacioskeletal syndrome 3 is associated with mutations in the ERCC5 gene on chromosome 13.
The ERCC5 protein participates in Repair DNA synthesis of ~27-30 bases long patch by POLD, POLE or POLK in GG-NER pathway.
ERCC5 is classified as a druggable target (Clinically Actionable and Druggable Genome categories) with score 4.4.
Genetic testing for ERCC5 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for cerebrooculofacioskeletal syndrome 3 has been reported in the published literature.
Phenotype severity distribution: 3 always present features, 5 common features.
No clinical trials have been registered for cerebrooculofacioskeletal syndrome 3.
3 publications have been identified in PubMed for cerebrooculofacioskeletal syndrome 3. Research spans Diagnostic / Biomarker (33%), Basic Science / Preclinical (33%), and Epidemiology / Natural History (33%).
El-Dessouky SH (2026). [PMID: 41795876](https://pubmed.ncbi.nlm.nih.gov/41795876/). *Ophthalmic genetics*. [Basic Science / Preclinical]
Sanabria-Salas MC (2025). [PMID: 40065011](https://pubmed.ncbi.nlm.nih.gov/40065011/). *European journal of human genetics : EJHG*. [Diagnostic / Biomarker]
Zhang J (2024). [PMID: 40626125](https://pubmed.ncbi.nlm.nih.gov/40626125/). *Pediatric discovery*. [Epidemiology / Natural History]
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 6:47 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Common questions about cerebrooculofacioskeletal syndrome 3
Brain and nerves |
2 |
Global developmental delay, Enlarged brain ventricles (ventriculomegaly) |
Skin | 1 | Cutaneous photosensitivity |
Arms and legs | 1 | Rocker bottom foot |
Muscles | 1 | Joint stiffness present at birth (arthrogryposis multiplex congenita) |
Pregnancy and birth | 1 | Decreased fetal movement |
Growth and development | 1 | Intrauterine growth retardation |